DrugPatentWatch Database Preview

Janssen R And D Company Profile

« Back to Dashboard

What is the competitive landscape for JANSSEN R AND D, and when can generic versions of JANSSEN R AND D drugs launch?

JANSSEN R AND D has two approved drugs.

There are four US patents protecting JANSSEN R AND D drugs.

There are one hundred and thirty-four patent family members on JANSSEN R AND D drugs in thirty-nine countries and twelve supplementary protection certificates in eleven countries.

Summary for Janssen R And D

International Patents:	134
US Patents:	4
Tradenames:	2
Ingredients:	2
NDAs:	2

Drugs and US Patents for Janssen R And D

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen R And D	PARAFON FORTE DSC	chlorzoxazone	TABLET;ORAL	011529-002	Jun 15, 1987		DISCN	Yes	No
Janssen R And D	INTELENCE	etravirine	TABLET;ORAL	022187-001	Jan 18, 2008		RX	Yes	No	8,003,789*PED				Y
Janssen R And D	INTELENCE	etravirine	TABLET;ORAL	022187-003	Mar 26, 2012		RX	Yes	No
Janssen R And D	INTELENCE	etravirine	TABLET;ORAL	022187-001	Jan 18, 2008		RX	Yes	No
Janssen R And D	INTELENCE	etravirine	TABLET;ORAL	022187-002	Dec 22, 2010		RX	Yes	Yes	8,003,789*PED				Y
Janssen R And D	INTELENCE	etravirine	TABLET;ORAL	022187-002	Dec 22, 2010		RX	Yes	Yes	7,037,917*PED				Y
Janssen R And D	INTELENCE	etravirine	TABLET;ORAL	022187-003	Mar 26, 2012		RX	Yes	No

International Patents for Janssen R And D Drugs

Country	Document Number	Estimated Expiration
Germany	122009000003
Poland	207590
Germany	69929354
Taiwan	I238161
Israel	169949
Indonesia	28376
European Patent Office	1002795

Supplementary Protection Certificates for Janssen R And D Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0004	France		PRODUCT NAME: ETRAVIRINE AINSI QUE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/08/468/001 DU 20080828; REGISTRATION NO/DATE AT EEC: EU/1/08/468/001 DU 20080828
2008016,C1002795	Lithuania		PRODUCT NAME: ETRAVIRINUM; REGISTRATION NO/DATE: EU/1/08/468/001 20080828
5/2009	Austria		PRODUCT NAME: ETRAVIRIN UND DESSEN ADDITIONSSALZE
C033/2008	Ireland		SPC033/2008: 20090914, EXPIRES: 20230827
2009 00004	Denmark
1002795/01	Switzerland		PRODUCT NAME: ETRAVIRIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58483 13.05.2008
7	Finland

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Janssen Biotech
• Janssen Pharma
• Janssen Pharms
• Janssen Prods
• Janssen R And D
• Janssen Res And Dev
• Janssen Therap